Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 1/2 Study of Inactivated Ross River Virus Vaccine in Healthy Adults
NCT00717834Phase 2Completed
- Sponsor
- Resilience Government Services
- Start
- Jun 2008
- Primary completion
- Oct 2008
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 3
01
Overview
A Phase 2 trial of inactivated Ross River virus vaccine in Ross River virus disease (RRV), sponsored by Resilience Government Services. Started Jun 2008; status: completed.
02
Drugs
inactivated Ross River virus vaccine
03
Conditions
Ross River virus disease (RRV)
Beyond the preview
Go deeper on NCT00717834.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00717834.